Sharyle Fowler
Sharyle Fowler
Assistant Professor, University of Saskatchewan
Verified email at
Cited by
Cited by
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
IBDPCG Nguyen GC, Seow CH, Maxwell C
Gastroenterology 150 (3), 734-757, 2016
SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease
SA Fowler, AN Ananthakrishnan, A Gardet, CR Stevens, JR Korzenik, ...
Journal of Crohn's and Colitis 8 (8), 845-851, 2014
Effects of cancer treatment on inflammatory bowel disease remission and reactivation
JE Axelrad, SA Fowler, S Friedman, AN Ananthakrishnan, V Yajnik
Clinical Gastroenterology and Hepatology 10 (9), 1021-1027. e1, 2012
Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance
W Duff, N Haskey, G Potter, J Alcorn, P Hunter, S Fowler
World Journal of Gastroenterology 24 (28), 3055, 2018
Endoscopist-administered propofol: a retrospective safety study
JWI Morse, SA Fowler, AL Morse
Canadian Journal of Gastroenterology 22 (7), 617-620, 2008
Efficacy and safety of natalizumab in Crohn’s disease patients treated at 6 Boston academic hospitals
P Juillerat, SK Wasan, SA Fowler, S Friedman, VK Pabby, JA Coukas, ...
Inflammatory bowel diseases 19 (11), 2457-2463, 2013
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
S Danese, JF Colombel, M Lukas, JP Gisbert, G D'Haens, B Hayee, ...
The lancet Gastroenterology & hepatology 7 (2), 118-127, 2022
Impact of an integrated model of care on outcomes of patients with inflammatory bowel diseases: Evidence from a population-based study
JN Peña-Sánchez, LM Lix, GF Teare, W Li, SA Fowler, JL Jones
Journal of Crohn's and Colitis 11 (12), 1471-1479, 2017
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised …
L Peyrin-Biroulet, A Hart, P Bossuyt, M Long, M Allez, P Juillerat, ...
The lancet Gastroenterology & hepatology 7 (2), 128-140, 2022
Development of a screening tool to detect nutrition risk in patients with inflammatory bowel disease
N Haskey, JN Pena-Sanchez, JL Jones, SA Fowler
Asia Pacific Journal of Clinical Nutrition 27 (4), 756-762, 2018
Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease
N GC, B K, A W, B B, J JL, W AV, F S, H S, H VW, K GG, K R, M SK, R J, ...
Inflammatory Bowel Disease 23 (6), 858-865, 2017
Influence of flaxseed lignan supplementation to older adults on biochemical and functional outcome measures of inflammation
Y Di, J Jones, K Mansell, S Whiting, S Fowler, L Thorpe, J Billinsky, ...
Journal of the American College of Nutrition 36 (8), 646-653, 2017
Elevation of serum pyruvate kinase M2 (PKM2) in IBD and its relationship to IBD indices
AA Almousa, M Morris, S Fowler, J Jones, J Alcorn
Clinical biochemistry 53, 19-24, 2018
Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn’s Disease
YV Pedamallu CD, Bhatt AS, Bullman S, Fowler S, Freeman SS, Durand J, Jung J ...
Cellular and Molecular Gastroenterology and Hepatology 2 (5), 563-566, 2016
Biomarker-based models outperform patient-reported scores in predicting endoscopic inflammatory disease activity
MW Morris, SA Stewart, C Heisler, WJ Sandborn, EV Loftus, GA Zello, ...
Inflammatory bowel diseases 24 (2), 277-285, 2018
Appropriateness of biologics in the management of Crohn’s disease using RAND/UCLA appropriateness methodology
AV Weizman, GC Nguyen, CH Seow, L Targownik, SK Murthy, K Boland, ...
Inflammatory bowel diseases 25 (2), 328-335, 2019
A prospective, randomized assessment of a spatial orientation device in natural orifice transluminal endoscopic surgery
S Fowler, MS Hefny, ECS Chen, RE Ellis, D Mercer, D Jalink, A Samis, ...
Gastrointestinal Endoscopy 73 (1), 123-127, 2011
Protocol for a 24-week randomized controlled study of once-daily oral dose of flax lignan to healthy older adults
J Alcorn, S Whiting, N Viveky, Y Di, K Mansell, S Fowler, L Thorpe, ...
JMIR research protocols 6 (2), e6817, 2017
Population-based evidence from a Western Canadian province of the decreasing incidence rates and trends of inflammatory bowel disease among adults
JA Osei, JN Peña-Sánchez, SA Fowler, N Muhajarine, GG Kaplan, LM Lix
Journal of the Canadian Association of Gastroenterology 4 (4), 186-193, 2021
W1212 hepatosplenic T-cell lymphoma in Crohn's disease. Where does the risk lie?
S Fowler, M Beyak, WT Depew, C Justinich, MJ Ropeleski
Gastroenterology 5 (138), S-675, 2010
The system can't perform the operation now. Try again later.
Articles 1–20